Patent application number | Description | Published |
20080242973 | HEART IMAGING WITH ADAPTIVE INVERSION TIME - In a method for acquisition of magnetic resonance images of the heart, MR signals of the heart are acquired using an imaging sequence, wherein the magnetization is inverted by an RF inversion pulse before the acquisition of the MR signals; and of the heart activity is detected, and the point in time of the switching of the RF inversion pulse dependent on the detected heart activity. | 10-02-2008 |
20100019765 | METHOD AND APPARATUS FOR ACQUIRING A MAGNETIC RESONANCE IMAGE OF TISSUE CONTAINING IRON OXIDE - In a method and apparatus for acquisition of a magnetic resonance (MR) image of tissue containing iron oxide particles frequency-selective inversion of the longitudinal magnetization in the tissue is done before acquisition of the MR image, and acquisition of the MR image is done at a zero crossing of the longitudinal magnetization. For water portions of the tissue, multiple inversion pulses that invert the longitudinal magnetization of the aqueous portions are radiated into the tissue. For fat portions of the tissue, multiple inversion pulses are radiated into the tissue that invert longitudinal magnetization of the fat portions. The inversion pulses for the respective tissue portions individually exhibit a fixed time interval from one another. | 01-28-2010 |
20100022870 | Method for implementing an imaging examination method - A method is disclosed for implementing an imaging examination method. In at least one embodiment, the method includes creating an overview data record containing angiography data relating to a patient; simulating flow conditions in vessels of the patient; determining a strain on the vascular walls with the aid of the simulation; identifying vascular regions, in which the strain on the vascular wall exceeds a threshold value and implementing an imaging examination in at least one of the identified vascular regions. | 01-28-2010 |
Patent application number | Description | Published |
20110185513 | APPARATUS AND METHOD FOR DETECTING UNBALANCED LOADS IN A WASHING MACHINE - An apparatus and techniques for detecting unbalanced load in a washing machine are provided. A clothes basket containing a load of clothing and rotatable about an axis is accelerated. As the clothes basket passes a first predetermined rotational speed, one of power and torque applied to the clothes basket is limited. It is determined whether the clothes basket accelerates from the first predetermined to a second predetermined rotational speed within a predetermined time. Failure to reach the second predetermined rotational speed within the predetermined time signifies an out-of-balance condition as to the load of clothing. No resonance of the machine lies between the first and second predetermined rotational speeds. In another aspect, a similar technique can be employed, with or without limiting power or torque, wherein a resonance does lie between the first and second predetermined rotational speeds. | 08-04-2011 |
20120055039 | DRYING AND WARMING APPLIANCE - An appliance for drying or warming associated laundry items includes a housing having a wall forming a stationary cavity dimensioned to receive the associated laundry items. At least one article support member is preferably contained within the cavity. A heater increases a temperature of associated air within the cavity and a fan circulates the heated air within the cavity. A vent is dimensioned to allow air to exit the housing cavity, and a controller regulates circulation of the associated heated air within the cavity. | 03-08-2012 |
20120103000 | DISPENSER RECESS WITH LIGHT PIPE AND REFRIGERATION APPLIANCE INCORPORATING SAME - An illuminated dispenser assembly may include a dispenser recess area defined by walls, such as a bottom wall, two side walls, a back wall and a top wall. A dispenser has an outlet extending through one of the walls of the dispenser recess area to dispense a substance from an interior area to the dispenser recess via the outlet. A lighting element is located for illuminating the dispenser recess. The lighting element includes at least one light source and at least one light pipe for transmitting light from the light source to the dispenser recess. The light source may be placed in different states and/or may illuminate with different colors depending on status, user selection, time of day, etc. | 05-03-2012 |
Patent application number | Description | Published |
20120127676 | ARRANGEMENT FOR CONNECTING ELECTRICAL CONDUCTORS TO TERMINAL CONNECTIONS OF INTERCONNECTED CELLS - In order that even the cell connectors ( | 05-24-2012 |
20120231320 | DEVICE FOR ELECTRICALLY INTERCONNECTING CELLS IN A BATTERY PACK BY MEANS OF CELL CONNECTORS AND BATTERY PACK WITH SUCH CELL CONNECTORS - A device for electrical interconnection of cells ( | 09-13-2012 |
20140308561 | CURRENT TAP ELEMENT FOR AN ENERGY STORAGE MODULE - The present invention refers to a current tap element for an energy storage module, comprising: a contact element made from a first metal for directly connecting to a pole of the energy storage module, a conductor element which is directly connected to the contact element and is made from a second metal differing from the first metal, an overmolded plastic covering which completely encloses the conductor element, and a connection in the plastic covering for contacting the conductor element. | 10-16-2014 |
20140322589 | HIGH-VOLTAGE STORAGE DEVICE - The present invention refers to a high-voltage battery for power supply, particularly of an automotive vehicle, comprising: an energy storage module with a plurality of electrochemical storage cells and a wall accommodating the plurality of storage cells, each storage cell comprising at least two electric connection terminals, and an upper part for contacting and covering the connection terminals, said upper part overlapping the wall in a contactless manner, so that a gap remains relative to the storage cells. | 10-30-2014 |
20140342620 | CELL CONTACTING ARRANGEMENT FOR AN ENERGY STORAGE DEVICE - The present invention relates to a cell contacting arrangement for an energy storage module having a plurality of electrochemical storage cells, each storage cell having at least two electric connection terminals, the arrangement comprising: a carrier plate which is mountable on the energy storage module, and at least one cell connector inserted into the carrier plate for connecting at least two of the connection terminals of different storage cells, the carrier plate comprising at least one catch spring having a detent for fixing the cell connector in the carrier plate. | 11-20-2014 |
Patent application number | Description | Published |
20100197659 | BIPHENYLCARBOXAMIDE DERIVATIVES AS HEDGEHOD PATHWAY MODULATORS - The invention provides a method for modulating the activity of the hedgehog signaling pathway. In particular, the invention provides a method for inhibiting aberrant growth states resulting from phenotypes such as Ptc loss-of-function, hedgehog gain-of-function, smoothened gain-of-function or Gli gain-of-function, comprising contacting a cell with a sufficient amount of a compound of Formula I. | 08-05-2010 |
20100216828 | METHODS AND COMPOSITIONS FOR TREATING CANCERS - This invention provides a combination of antagonists of the hedgehog signaling pathway with a BCR-ABL inhibitor. The combination of the present invention may be used for treating cancers known to be associated with protein tyrosine kinases such as, for example, Src, BCR-ABL and c-kit. | 08-26-2010 |
20110021524 | COMPOSITIONS AND METHODS FOR TREATING CANCERS - This invention provides a combination of ATP-competitive BCR-ABL inhibitor and a non-ATP competitive BCR-ABL inhibitor. The combination of the present invention may be used for treating cancers known to be associated with BCR-ABL. | 01-27-2011 |
20110044991 | METHODS AND COMPOSITIONS FOR TREATING LYMPHOMA AND MYELOMA - This invention relates to the use of antagonists of the hedgehog signaling pathway to induce apoptosis of lymphoma and myeloma cells and to treat subjects suffering from various forms of lymphoma or myeloma. | 02-24-2011 |
20110166058 | ORGANIC COMPOSITIONS TO TREAT HSF1-RELATED DISEASES - The present disclosure relates to methods of treating heat shock factor 1 (HSF1)-related diseases such as cancer and viral diseases, using a therapeutically effective amount of a RNAi agent to HSF. | 07-07-2011 |
20110245256 | USE OF A PKC INHIBITOR - The present invention demonstrates that chronic active BCR signaling through CD79A/B confers a strong dependence on downstream PKCb kinase signaling. Hence, provided herein is a method for inhibiting the growth of B-cell lymphoma having chronic active B-cell-receptor signaling, or inhibiting the growth of cancers with molecular lesions that lead to chronic active BCR signaling, by administering to a patient in need of such treatment a therapeutically effective amount of a PKC inhibitor or a use of a PKC inhibitor to inhibit the growth of B-cell lymphoma having chronic active B-cell-receptor signaling or to inhibit the growth of cancers with molecular lesions that lead to chronic active BCR signaling. | 10-06-2011 |
20120165355 | METHODS AND COMPOSITIONS FOR TREATING CANCERS - This invention provides a combination of antagonists of the hedgehog signaling pathway with a BCR-ABL inhibitor. The combination of the present invention may be used for treating cancers known to be associated with protein tyrosine kinases such as, for example, Src, BCR-ABL and c-kit. | 06-28-2012 |
20130210771 | METHODS AND COMPOSITIONS FOR TREATING CANCERS - This invention provides a combination of antagonists of the hedgehog signaling pathway with a BCR-ABL inhibitor. The combination of the present invention may be used for treating cancers known to be associated with protein tyrosine kinases such as, for example, Src, BCR-ABL and c-kit. | 08-15-2013 |
20150291954 | ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES - The present disclosure relates to RNAi agents useful in methods of treating Beta-Catenin-related diseases such as adenomatous polyposis of the colon, colorectal cancer, basal cell carcinoma, breast cancer, kidney cancer, Wilms tumors, medulloblastoma, ovarian cancer, adrenocortical tumors, gastric cancer, liver cancer, melanoma, pancreatic cancers, prostate cancer, renal cancer, ectopic teeth and taste papillae, skin cancer, pilomatrixoma, anaplastic thyroid carcinoma, and uterine carcinosarcoma, oligodontia, osteoporosis, ageing, degenerative diseases, bedsores, chronic wounds and impaired wound healing, and similar and related diseases, using a therapeutically effective amount of a RNAi agent to Beta-Catenin. | 10-15-2015 |
Patent application number | Description | Published |
20120129914 | ORGANIC COMPOSITIONS TO TREAT HSF1-RELATED DISEASES - The present disclosure relates to methods of treating heat shock factor 1 (HSF1)-related diseases such as cancer and viral diseases, using a therapeutically effective amount of a RNAi agent to HSF. | 05-24-2012 |
20120129915 | ORGANIC COMPOSITIONS TO TREAT HSF1-RELATED DISEASES - The present disclosure relates to methods of treating heat shock factor 1 (HSF1)-related diseases such as cancer and viral diseases, using a therapeutically effective amount of a RNAi agent to HSF. | 05-24-2012 |
20140039039 | ORGANIC COMPOSITIONS TO TREAT HSF1-RELATED DISEASES - The present disclosure relates to methods of treating heat shock factor 1 (HSF1)-related diseases such as cancer and viral diseases, using a therapeutically effective amount of a RNAi agent to HSF. | 02-06-2014 |
20150238515 | ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES - The present disclosure relates to RNAi agents useful in methods of treating KRAS-related diseases such as a proliferative disease, including without limitation a solid or liquid cancer, adenocarcinoma, colorectal cancer, advanced and/or metastatic colorectal cancer, colon cancer, lung, non-small cell lung cancer and lung adenocarcinoma, acute myelogenous lung, bladder, brain, breast, cervical, endometrial, gastric, head and neck, kidney, leukemia, myelodysplastic syndrome, myeloid leukemia, liver, melanoma, ovarian, pancreatic, prostate, testicular, thyroid cancers, and cardio-facio-cutaneous (CFC) syndrome and Noonan syndrome, and similar and related diseases, using a therapeutically effective amount of a RNAi agent to KRAS. | 08-27-2015 |
20150284721 | ORGANIC COMPOSITIONS TO TREAT HSF1-RELATED DISEASES - The present disclosure relates to methods of treating heat shock factor 1 (HSF1)-related diseases such as cancer and viral diseases, using a therapeutically effective amount of a RNAi agent to HSF. | 10-08-2015 |